![Robert Hopfner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Hopfner
Director/Board Member at
RALLYBIO CORPORATION
Net worth: 53 506 $ as of 2026-06-29
Profile
Robert L.
Hopfner currently serves as Director at Oculis SA and Rallybio Holdings LLC.
He is Director at Plexium, Inc. since 2021 and Independent Director at Rallybio Corp.
since 2020.
He is Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC since 2017.
Former roles include Director at Hyperion Therapeutics, Inc. from 2010 to 2013, Director at Oculis Holding AG, Managing Director at Bay City Capital LLC, Director at Durata Therapeutics, Inc., Director at Altheos, Inc., Independent Director at Civitas Therapeutics, Inc., Independent Director at Vaxcyte, Inc. from 2017 to 2021, Independent Director at Entasis Therapeutics, Inc., Director at Iterum Therapeutics Plc from 2017 to 2018, Director at Imara, Inc., Director at Entasis Therapeutics Holdings, Inc., Independent Director at Inozyme Pharma, Inc. from 2018 to 2025, and Associate at DuPont Pharmaceuticals Co. Education includes undergraduate and doctorate degrees from the University of Saskatchewan and an MBA from The University of Chicago Booth School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EVOMMUNE, INC. 0.01% | 2026-03-30 | 4,026 ( 0.01% ) | 53 506 $ | 2026-06-29 |
RALLYBIO CORPORATION -.--% | 2025-12-18 | 0 ( -.--% ) | - $ | 2026-06-29 |
Robert Hopfner active positions
| Companies | Position | Start |
|---|---|---|
| EVOMMUNE, INC. | Director/Board Member | 2020-06-30 |
| RALLYBIO CORPORATION | Director/Board Member | 2020-02-29 |
Plexium, Inc.
 Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Director/Board Member | 2021-01-20 |
Rallybio Holdings LLC
 Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Director/Board Member | - |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Private Equity Investor | 2017-09-30 |
Oculis SA
 Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Director/Board Member | - |
Former positions of Robert Hopfner
| Companies | Position | End |
|---|---|---|
| INOZYME PHARMA, INC. | Director/Board Member | 2025-06-30 |
| VAXCYTE, INC. | Director/Board Member | 2021-09-15 |
| ITERUM THERAPEUTICS PLC | Director/Board Member | 2018-05-23 |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Robert Hopfner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
71
1st degree connections
21
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 21 |
|---|---|
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Altheos, Inc.
 Altheos, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Commercial Services |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Finance |
Rallybio Holdings LLC
Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
Plexium, Inc.
Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Health Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Oculis Holding AG
 Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
- Stock Market
- Insiders
- Robert Hopfner
